| Financial Year |
March 31 2023 |
| Monetary Funds |
219,533,073.55 |
| Held-for-trading Financial Assets |
121,972.40 |
| Notes Receivable |
3,085,565.99 |
| Accounts Receivable |
364,733,272.83 |
| Advances to Suppliers |
11,659,565.78 |
| Other Receivables |
45,848,114.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
402,087,317.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
159,492.01 |
| Total Current Assets |
1,061,716,336.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,388,877.81 |
| Investment Properties |
-- |
| Fixed Assetes |
754,533,891.53 |
| Under-construction Projects |
274,827,581.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
14,283,187.81 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
212,269,616.70 |
| R&D expenses |
161,670,303.35 |
| Goodwill |
1,900,200.00 |
| Long-Term Deferred and Prepaid Expenses |
732,954.01 |
| Deferred Income Tax Assets |
15,246,524.07 |
| Other Non-Current Assets |
10,427,197.79 |
| Sub-Total of Non-Current Assets |
3,438,804,969.80 |
| Total Assets |
4,500,521,306.00 |
| Short-Term Loans |
130,117,500.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,776,965.04 |
| Accounts Payable |
198,202,491.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,492,622.98 |
| Taxes Payable |
12,103,325.21 |
| Interest Payable |
-- |
| Dividend Payable |
3,591,660.93 |
| Other payables |
104,819,329.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,287,561.85 |
| Sub-Total of Current Liabilities |
483,376,032.71 |
| Long-term Loans |
1,563,550,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,257,518.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,641,922,729.96 |
| Total Liabilities |
2,125,298,762.67 |
| Paid-In Capital(Or Share Stock) |
966,494,707.00 |
| Capital Surplus |
3,642,429,372.40 |
| Surplus Reserve |
108,648,108.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,373,750,326.37 |
| Minority Stockholder's Interest |
31,400,681.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,343,821,861.62 |
| Owner's Equity（Stockholder's Equity） |
2,375,222,543.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,500,521,306.00 |
